Reducing the Agonist Activity of Antiandrogens by a Dominant-Negative Androgen Receptor Coregulator ARA70 in Prostate Cancer Cells

Journal of Biological Chemistry - United States
doi 10.1074/jbc.m210941200
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Hypoxia Increases Androgen Receptor Activity in Prostate Cancer Cells

Cancer Research
Cancer ResearchOncology
2006English

The Liver X Receptor Agonist T0901317 Acts as Androgen Receptor Antagonist in Human Prostate Cancer Cells

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2007English

Increased Expression of Androgen Receptor Coregulator MAGE-11 in Prostate Cancer by DNA Hypomethylation and Cyclic AMP

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2009English

Reprogramming of Isocitrate Dehydrogenases Expression and Activity by the Androgen Receptor in Prostate Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

Activation of P300 Histone Acetyltransferase Activity and Acetylation of the Androgen Receptor by Bombesin in Prostate Cancer Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

Maintaining and Reprogramming Genomic Androgen Receptor Activity in Prostate Cancer

Nature Reviews Cancer
Cancer ResearchOncology
2014English

Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer

Cancer Research
Cancer ResearchOncology
2010English

Stromal-Epithelial Cell Interactions and Androgen Receptor-Coregulator Recruitment Is Altered in the Tissue Microenvironment of Prostate Cancer

Cancer Research
Cancer ResearchOncology
2007English

Altered Androgen Receptor Activity Drives CHD1-Null Prostate Cancer

Cancer Discovery
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy